In vivo pathogenicity of Trichosporon asahii isolates with different in vitro enzymatic profiles in an immunocompetent murine model of systemic trichosporonosis
- PMID: 28992352
- DOI: 10.1093/mmy/myx057
In vivo pathogenicity of Trichosporon asahii isolates with different in vitro enzymatic profiles in an immunocompetent murine model of systemic trichosporonosis
Abstract
Trichosporon asahii is an opportunistic yeastlike fungus that colonizes the gastrointestinal and respiratory tracts and human skin. Although it is an important cause of disseminated infections by non-Candida species, there are a few reports related to its virulence factors and their possible role in in vivo pathogenicity. We developed a murine model of disseminated trichosporonosis in immunocompetent mice for the evaluation of the in vivo pathogenicity of 6 T. asahii isolates with different in vitro virulence factor profiles. Tissue fungal burden was determined on days 1, 3, 7, 15, and 25 post-challenge. Overall, the largest fungal load was detected in the kidney on the 5 experimental days, while brain, spleen, and liver displayed a comparatively low fungal count. We observed a fungal burden decrease in most experimental groups from day 15. Histological analysis showed the presence of T. asahii in tissue and a generalized inflammatory infiltrate of polymorphonuclear cells in the kidney, liver, red pulp of the spleen, and the hippocampus. Even though our isolates showed different in vitro virulence factors profiles, we did not detect relevant differences when assayed in vivo, except for a higher persistence of a protease- and biofilm-producing strain in kidney, liver, and brain.
Similar articles
-
The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.Virulence. 2015;6(5):476-86. doi: 10.1080/21505594.2015.1020273. Epub 2015 Mar 9. Virulence. 2015. PMID: 25751127 Free PMC article.
-
Therapeutic efficacy of posaconazole in a murine model of disseminated trichosporonosis.J Antimicrob Chemother. 2014 Apr;69(4):1075-8. doi: 10.1093/jac/dkt466. Epub 2013 Nov 19. J Antimicrob Chemother. 2014. PMID: 24252752
-
Biofilm formation and antifungal susceptibility of Trichosporon asahii isolates from Mexican patients.Rev Iberoam Micol. 2018 Jan-Mar;35(1):22-26. doi: 10.1016/j.riam.2017.02.008. Epub 2017 Dec 26. Rev Iberoam Micol. 2018. PMID: 29287630
-
[An overview on Trichosporon asahii and its infections].Mikrobiyol Bul. 2012 Oct;46(4):707-15. Mikrobiyol Bul. 2012. PMID: 23188586 Review. Turkish.
-
The Cell Biology of the Trichosporon-Host Interaction.Front Cell Infect Microbiol. 2017 Apr 7;7:118. doi: 10.3389/fcimb.2017.00118. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 28439501 Free PMC article. Review.
Cited by
-
Identification, genotyping, and pathogenicity of Trichosporon spp. Isolated from Giant pandas (Ailuropoda melanoleuca).BMC Microbiol. 2019 May 28;19(1):113. doi: 10.1186/s12866-019-1486-7. BMC Microbiol. 2019. PMID: 31138125 Free PMC article.
-
A critical role of calcineurin in stress responses, hyphal formation, and virulence of the pathogenic fungus Trichosporon asahii.Sci Rep. 2022 Sep 27;12(1):16126. doi: 10.1038/s41598-022-20507-x. Sci Rep. 2022. PMID: 36167890 Free PMC article.
-
Development of an efficient gene-targeting system for elucidating infection mechanisms of the fungal pathogen Trichosporon asahii.Sci Rep. 2021 Sep 14;11(1):18270. doi: 10.1038/s41598-021-97287-3. Sci Rep. 2021. PMID: 34521867 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources